Aarti Drugs Limited

Pharmaceuticals

AARTIDRUGS-EQ: NSEBSE: 4481

Aarti Drugs Limited (AARTIDRUGS-EQ) live share price today at NSE / BSE

INR 428.35

+4.05 (0.95%)1 Day

Thu, 17 Sept 2026, 02:30 PM

About AARTIDRUGS-EQ

Aarti Drugs Ltd is a leading Indian pharmaceutical company specializing in the manufacturing and export of active pharmaceutical ingredients (APIs), intermediates, and specialty chemicals. Established in 1984, the company operates primarily in the therapeutic segments of anti-diarrheal, anti-diabetic, anti-inflammatory, anti-fungal, and anti-cholesterol drugs. Aarti Drugs has a strong global footprint, exporting products to over 100 countries, and maintains a diversified customer base comprised of major global pharmaceutical firms and large generic companies.

52 Week Range

HighINR 534.55

LowINR 318.95

Current Signal

green

Open

INR 419.20

High

INR 437.70

Low

INR 419.20

Prev. Close

INR 424.30

Volume

1,20,340

Avg. Volume (7D)

1,38,923

Avg. Volume (10D)

1,72,289

Latest Signal

Buy

Buy Price

INR 424.4

Close Price

INR 427.1

Change

4.62%

Stoploss

INR 411.7

Signal Date

2026-09-01

Hold

Yes

Pattern

Bullish Engulfing

Company Snapshot

CIN	L37060MH1984PLC055433
Industry	Pharmaceuticals
Market Lot	1
Impact Cost	0.09%
Listing Date	12 Sept 1993
BC Record Date	RD 04/02/2025
Registered Address	Plot No N-198, MIDC, Tarapur, Village Pamtembhi, Taluka Palghar
Auditor	Kirtane & Pandit, LLP,Gokhale and Sathe

Registrar

Name

MUFG Intime India Pvt. Ltd

Telephone

022 - 49186270

Website

www.in.mpms.mufg.com

Shareholding Pattern

Quarterly filing · 30 Jun 2026

Promoter & Promoter Group54.43%

Non-Institutions40.27%

Domestic Institutions0.08%

Board of Directors

AdhishPPatilChief Financial Officer

Mr.Ajit Eledath VenugopalanNon-Executive - Independent Director

Mr.Ankit Vikram PalejaNon-Executive - Independent Director

Mr.Bhaskar Narayan ThoratNon-Executive - Independent Director

Mr.Harit Pragji ShahExecutive Director

Mr.Harshit Manilal SavlaExecutive Director-MD

Mr.Hasmukh Bhavanji DedhiaNon-Executive - Independent Director

Mr.Narendra Jagannath SalviNon-Executive - Non Independent Director

Mr.Prakash Moreshwar PatilExecutive Director-Chairperson-CEO-MD

Mr.Rashesh Chandrakant GogriExecutive Director-MD

Mr.RushikeshDeoleCompany Secretary & Compliance Officer

Mr.Sandeep Madhusudan JoshiNon-Executive - Independent Director

Mr.Uday Moreshwar PatilExecutive Director

Mrs.Neha Rajen GadaNon-Executive - Independent Director

Today Share Price

Aarti Drugs Limited

Particulars	Details
Opening Price	INR 419.20
Previous Closing Price	INR 424.30
Volume of Aarti Drugs Limited	1,20,340
Value of Share	—

Today NSE Share Price

Aarti Drugs Limited

Particulars	Details
Live Share Price NSE India	INR 428.35
Previous Closing Price	INR 424.30
Open Price	INR 419.20
High	INR 437.70
Low	INR 419.20

Today BSE Share Price

Aarti Drugs Limited

Particulars	Details
Live Share Price BSE India	INR 428.35
Previous Closing Price	INR 424.30
Open Price	INR 419.20
High	INR 437.70
Low	INR 419.20

Aarti Drugs Limited

Backed by robust manufacturing infrastructure with multiple USFDA, EDQM, and WHO-GMP certified plants, the company continually invests in process innovation, cost efficiencies, and expanding its product portfolio. Aarti Drugs focuses on forward integration, new chemistry entities, capacity expansions, and adhering to stringent quality standards, enabling it to cater to both regulated and semi-regulated markets worldwide.

Frequently Asked Questions – StockYaari Stock Page

Every stock page on StockYaari is built to give investors a complete picture of a company before they act on any idea. Below are the most common questions users ask about how this page works, what it shows, and how to make the most of it while researching a company.

Final Thoughts

Taken together, these sections are what make a StockYaari stock page useful for both quick decisions and deeper research. Whether someone is checking a live price during market hours, studying a company's fundamentals before investing for the long term, or simply confirming whether an analyst has an active call on a stock, everything sits in one organised place. New users are encouraged to explore each section at their own pace, since familiarity with the layout makes future research faster and more confident over time.